Whole Genome Bisulfite Sequencing (WGBS) is a high-resolution technique used to map DNA methylation across the entire genome at single-base resolution. It involves the treatment of DNA with sodium bisulfite, which converts unmethylated cytosines into uracils (read as thymine during sequencing), while leaving methylated cytosines unchanged.
By sequencing the bisulfite-treated DNA and comparing it to the reference genome, researchers can precisely detect 5-methylcytosine (5mC) patterns — an important epigenetic modification linked to gene regulation, development, and disease.
Purpose: Profile DNA methylation genome-wide
Input: High-quality genomic DNA
Methylation Type Detected: Primarily 5-methylcytosine (5mC) in CpG, CHG, and CHH contexts
Output: Methylation status of individual cytosines across the genome
Applications: Epigenetic regulation, cancer research, developmental biology, imprinting disorders
DNA Extraction
High-purity genomic DNA is isolated from cells or tissues.
Bisulfite Conversion
DNA is treated with sodium bisulfite, which converts unmethylated cytosines to uracils, while methylated cytosines remain unchanged.
Library Preparation
Bisulfite-converted DNA is fragmented, adapter-ligated, and PCR-amplified.
Sequencing
Libraries are sequenced on high-throughput platforms (e.g., Illumina NovaSeq, HiSeq).
Data Analysis
Specialized tools align the bisulfite reads and calculate methylation ratios at each cytosine.
Genome-Wide DNA Methylation Profiling
Understand epigenetic regulation across the whole genome.
Cancer Epigenomics
Identify tumor-specific methylation changes, epigenetic silencing of tumor suppressors, or activation of oncogenes.
Developmental Biology
Study dynamic methylation changes during embryogenesis, cell differentiation, or aging.
Environmental Epigenetics
Assess how toxins, diet, or stress affect methylation patterns.
Imprinting and X-Inactivation
Examine allele-specific methylation in imprinted genes and dosage compensation.
Epigenetic Biomarker Discovery
Discover novel diagnostic, prognostic, or therapeutic methylation signatures.
Single-Base Resolution
Precise detection of methylated and unmethylated cytosines.
Genome-Wide Coverage
Unlike array-based methods, WGBS covers both CpG-rich and CpG-poor regions.
Quantitative Output
Provides methylation levels as a percentage at each site.
Detects Non-CpG Methylation
Especially relevant in embryonic stem cells and neurons.
Unbiased
Does not rely on probes or preselected regions.
Feature | Description |
---|---|
Resolution | Single-nucleotide methylation resolution |
Contexts Covered | CpG, CHG, CHH (where H = A, C, or T) |
Sequencing Depth | Typically 30–100× for reliable quantification |
Sample Input | ~100 ng to 1 µg of high-quality DNA |
Platform Compatibility | Illumina (most common), ONT & PacBio (for long-read methylation) |
Data Output | BAM files, methylation call files (e.g., .bedGraph, .txt) |
DNA Degradation
Bisulfite treatment can fragment DNA, reducing yield and requiring optimized protocols.
High Sequencing Cost
Due to whole genome coverage, deep sequencing is required (~30–60x), increasing cost.
Bioinformatics Intensive
Requires specialized tools and high computational resources.
Cannot Distinguish 5mC from 5hmC
Standard WGBS detects 5-methylcytosine but not 5-hydroxymethylcytosine unless additional methods are used.
PCR Bias
Amplification steps can introduce bias in methylation quantification.
Alignment: Bismark, BS-Seeker2, bwa-meth
Methylation Calling: MethylDackel, MethylKit, Bismark
Quality Control: FastQC, Qualimap, Trim Galore (bisulfite mode)
Differential Methylation: DSS, DMRcaller, MethPipe
Visualization: IGV (bisulfite mode), MethGo, UCSC Genome Browser
Annotation: Bedtools, HOMER, annotatr, Bioconductor packages